Technology
THE REALREAL ANNOUNCES SECOND QUARTER 2026 RESULTS
Published
2 months agoon
By
Company Raises Full Year Guidance Following Second Quarter Results Above the High End of Outlook with Record Quarterly GMV and Meaningful Margin Expansion
SAN FRANCISCO, Aug. 6, 2026 /PRNewswire/ — The RealReal, Inc. (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today reported financial results for its second quarter ended June 30, 2026. Second quarter 2026 gross merchandise value (GMV) and total revenue increased 22% and 17% compared to the second quarter of 2025, respectively. Consignment revenue grew 15% compared to the prior year period, and Direct Revenue grew 26% year-over-year in the second quarter. During the quarter, gross margin of 74.4% improved 10 basis points compared to the same period in 2025. Second quarter Adjusted EBITDA margin was 7.0%, an increase of 290 basis points versus the prior year period.
“The RealReal delivered a standout second quarter, with an all-time high quarterly GMV of $617 million, up 22% year-over-year. That marks our fourth consecutive quarter of GMV growth above 20%. Revenue grew 17% and we delivered nearly 300 basis points of Adjusted EBITDA margin expansion versus last year,” said Rati Levesque, Chief Executive Officer of The RealReal. “We’re upleveling the customer experience, deepening trust and compounding our advantages. Our buyers are spending more, our sellers are more engaged, and the platform connecting them gets smarter every quarter.”
Levesque continued, “Entering the year, we said 2026 would be the year our advantages begin to compound, and we’re delivering on that commitment. Given the continued strength in our supply trends and the durability of our growth, we are confidently raising our full-year outlook. We are entering the second half of the year from a position of strength, with a flywheel that is gaining real momentum.”
Second Quarter Highlights
GMV was $617 million, an increase of 22% compared to the same period in 2025Total Revenue was $193 million, an increase of 17% compared to the same period in 2025Gross Profit was $143 million, an increase of $21 million compared to the same period in 2025Gross Margin was 74.4%, an increase of 10 basis points compared to the same period in 2025 Net Loss was $(27) million or (14.1)% of total revenue, compared to $(11) million or (6.9)% of total revenue in the same period in 2025. Second Quarter 2026 Net Loss includes a $(18.6) million non-cash adjustment as a result of the change in fair value of warrant liability.Adjusted EBITDA was $13.5 million or 7.0% of total revenue compared to $6.8 million or 4.1% of total revenue in the same period in 2025GAAP basic net loss per share was $(0.23) compared to $(0.10) in the prior year period and GAAP diluted net loss per share was $(0.23) compared to $(0.13) in the prior year periodNon-GAAP basic and diluted net loss attributable to common stockholders per share was $(0.01) compared to $(0.06) in the prior year periodTop-line-related MetricsTrailing twelve months active buyers was 1,107,000, an increase of 11% compared to the same period in 2025Average order value (AOV) was $659, an increase of 13% versus the same period in 2025
Q3 and Full Year 2026 Guidance
Based on market conditions as of August 6, 2026, we are raising our full year guidance. Additionally, we are providing guidance for third quarter 2026 GMV, Total Revenue and Adjusted EBITDA, which is a Non-GAAP financial measure.
We have not reconciled forward-looking Adjusted EBITDA to net income (loss), the most directly comparable GAAP measure, because we cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations including payroll tax expense on employee stock transactions that are not within our control, or other components that may arise, without unreasonable effort. For these reasons, we are unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net income (loss).
Q3 2026
Full Year 2026
GMV
$610 – $620 million
$2.535 – $2.565 billion
Total Revenue
$194 – $198 million
$788 – $797 million
Adjusted EBITDA
$13.5 – $14.5 million
$66.0 – $69.0 million
Webcast and Conference Call
The RealReal will host a conference call to review the company’s second quarter results beginning at approximately 2:00 p.m. Pacific Time today (5:00 p.m. Eastern Time). A live webcast of the conference call and accompanying materials will be available online at investor.therealreal.com. A replay of the webcast will be available at the same location. To access the conference please register using this link:
https://the-realreal-earnings-call-q2-2026.open-exchange.net/registration.
About The RealReal, Inc.
The RealReal is the world’s largest online marketplace for authenticated, resale luxury goods, trusted by more than 40 million members. Our full-service consignment model—offering virtual appointments, in-home pickup, drop-off, and direct shipping—enables consumers to buy and sell luxury across fashion, fine jewelry and watches, art, and home categories with ease. The company combines a rigorous, expert-led authentication process with proprietary technology, including AI and machine learning, to power optimal pricing and processing for our members and to help scale the business. By extending the life of millions of luxury goods, the company is leading a more circular economy, all the while delivering a seamless experience for buyers and sellers.
Forward Looking Statements
This press release contains forward-looking statements relating to, among other things, the future performance of The RealReal that are based on the company’s current expectations, forecasts and assumptions and involve risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expect,” “plan,” “anticipate,” “target,” “contemplate,” “project,” “believe,” “estimate,” “predict,” “intend,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology. These statements include, but are not limited to, statements about future operating and financial results, including our strategies, plans, commitments, objectives and goals, in particular in the context of the recent geopolitical events, and uncertainty surrounding macro-economic trends, financial guidance, anticipated growth in 2026, the anticipated impact of generative AI, and financial targets, goals and projections. Actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of future performance. Other factors that could cause or contribute to such differences include, but are not limited to, inflation, macroeconomic uncertainty, geopolitical instability, any failure to generate a supply of consigned goods, pricing pressure on the consignment market resulting from discounting in the market for new goods, failure to efficiently and effectively operate our merchandising and fulfillment operations, labor shortages and other reasons.
More information about factors that could affect the company’s operating results is included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s most recent Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Reports on Form 10-Q, copies of which may be obtained by visiting the company’s Investor Relations website at https://investor.therealreal.com or the SEC’s website at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to the company on the date hereof. The company assumes no obligation to update such statements.
Non-GAAP Financial Measures
To supplement our unaudited and condensed financial statements presented in accordance with generally accepted accounting principles (“GAAP”), this earnings release and the accompanying tables and the related earnings conference call contain certain non-GAAP financial measures, including Adjusted EBITDA, Adjusted EBITDA as a percentage of total revenue (“Adjusted EBITDA Margin”), free cash flow, non-GAAP net loss attributable to common stockholders, and non-GAAP net loss per share attributable to common stockholders, basic and diluted. We have provided a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures in this earnings release.
We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors should also note that non-GAAP financial measures we use may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as that of other companies, including other companies in our industry.
Adjusted EBITDA is a key performance measure that our management uses to assess our operating performance. Because Adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure as an overall assessment of our performance, to evaluate the effectiveness of our business strategies and for business planning purposes. Adjusted EBITDA may not be comparable to similarly titled metrics of other companies.
We calculate Adjusted EBITDA as net income (loss) before interest income, interest expense, provision (benefit) for income taxes, depreciation and amortization, further adjusted to exclude stock-based compensation, employer payroll tax expense on employee stock transactions, gain on extinguishment of debt, change in fair value of warrant liabilities and certain one-time expenses. The employer payroll tax expense related to employee stock transactions are tied to the vesting or exercise of underlying equity awards and the price of our common stock at the time of vesting, which may vary from period to period independent of the operating performance of our business. Adjusted EBITDA has certain limitations as the measure excludes the impact of certain expenses that are included in our statements of operations that are necessary to run our business and should not be considered as an alternative to net income (loss) or any other measure of financial performance calculated and presented in accordance with GAAP.
In particular, the exclusion of certain expenses in calculating Adjusted EBITDA and Adjusted EBITDA Margin facilitates operating performance comparisons on a period-to-period basis and, in the case of exclusion of the impact of stock-based compensation and the related employer payroll tax expense on employee stock transactions, excludes an item that we do not consider to be indicative of our core operating performance. Investors should, however, understand that stock-based compensation and the related employer payroll tax expense will be a significant recurring expense in our business and an important part of the compensation provided to our employees. Accordingly, we believe that Adjusted EBITDA and Adjusted EBITDA Margin provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.
Free cash flow is a non-GAAP financial measure that is calculated as net cash (used in) provided by operating activities less net cash used to purchase property and equipment and capitalized proprietary software development costs. We believe free cash flow is an important indicator of our business performance, as it measures the amount of cash we generate. Accordingly, we believe that free cash flow provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management.
Non-GAAP net loss per share attributable to common stockholders, basic and diluted is a non-GAAP financial measure that is calculated as GAAP net loss plus stock-based compensation expense, provision (benefit) for income taxes, payroll tax expense on employee stock transactions, gain on extinguishment of debt, change in fair value of warrant liabilities and certain one-time expenses divided by weighted average shares outstanding. We believe that making these adjustments before calculating per share amounts for all periods presented provides a more meaningful comparison between our operating results from period to period.
THE REALREAL, INC.
Statements of Operations
(In thousands, except share and per share data)
(Unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
Revenue:
Consignment revenue
$ 148,216
$ 128,620
$ 294,109
$ 252,434
Direct revenue
25,787
20,495
51,595
40,949
Shipping services revenue
18,568
16,073
36,582
31,838
Total revenue
192,571
165,188
382,286
325,221
Cost of revenue:
Cost of consignment revenue
16,075
13,761
31,522
26,715
Cost of direct revenue
20,407
17,185
40,691
32,420
Cost of shipping services revenue
12,887
11,566
25,537
23,387
Total cost of revenue
49,369
42,512
97,750
82,522
Gross profit
143,202
122,676
284,536
242,699
Operating expenses:
Marketing
18,382
15,548
36,939
31,403
Operations and technology
74,706
68,986
147,425
135,964
Selling, general and administrative
52,397
48,027
104,729
97,988
Total operating expenses (1)
145,485
132,561
289,093
265,355
Loss from operations
(2,283)
(9,885)
(4,557)
(22,656)
Change in fair value of warrant liability
(18,583)
4,537
28,752
47,040
Gain on extinguishment of debt
—
—
—
37,101
Interest income
902
1,109
1,903
2,483
Interest expense
(7,322)
(7,038)
(14,543)
(13,358)
Other income, net
154
—
357
608
Income (loss) before provision for income taxes
(27,132)
(11,277)
11,912
51,218
Provision for income taxes
101
89
209
184
Net income (loss) attributable to common stockholders
$ (27,233)
$ (11,366)
$ 11,703
$ 51,034
Net income (loss) per share attributable to common
stockholders
Basic
$ (0.23)
$ (0.10)
$ 0.10
$ 0.45
Diluted
$ (0.23)
$ (0.13)
$ (0.13)
$ (0.27)
Weighted average shares used to compute net income (loss)
per share attributable to common stockholders
Basic
121,023,931
114,044,057
120,277,907
113,046,607
Diluted
121,023,931
119,484,716
126,390,826
120,178,570
(1) Includes stock-based compensation as follows:
Marketing
$ 422
$ 424
$ 767
$ 727
Operations and technology
2,580
2,677
4,557
4,901
Selling, general and administrative
4,573
5,107
8,524
9,939
Total
$ 7,575
$ 8,208
$ 13,848
$ 15,567
THE REALREAL, INC.
Condensed Balance Sheets
(In thousands, except share and per share data)
(Unaudited)
June 30,
2026
December 31,
2025
Assets
Current assets
Cash and cash equivalents
$ 119,132
$ 151,231
Accounts receivable, net
20,073
23,822
Inventory, net
35,431
30,843
Prepaid expenses and other current assets
18,682
21,595
Total current assets
193,318
227,491
Property and equipment, net
100,558
96,148
Operating lease right-of-use assets
63,240
64,641
Restricted cash
14,777
14,808
Other assets
6,394
5,945
Total assets
$ 378,287
$ 409,033
Liabilities and Stockholders’ Deficit
Current liabilities
Accounts payable
$ 15,049
$ 14,565
Accrued consignor payable
95,062
111,497
Operating lease liabilities, current portion
23,095
24,645
Other accrued and current liabilities
100,274
113,533
Total current liabilities
233,480
264,240
Operating lease liabilities, net of current portion
64,404
66,793
Convertible Senior Notes, net
231,516
230,833
Non-convertible notes, net
144,293
140,980
Warrant liability
74,688
114,353
Other noncurrent liabilities
7,636
7,352
Total liabilities
756,017
824,551
Stockholders’ deficit:
Common stock, $0.00001 par value; 500,000,000 shares authorized as of June 30,
2026, and December 31, 2025; 121,666,258 and 118,318,917 shares issued and
outstanding as of June 30, 2026, and December 31, 2025, respectively
1
1
Additional paid-in capital
906,192
880,107
Accumulated deficit
(1,283,923)
(1,295,626)
Total stockholders’ deficit
(377,730)
(415,518)
Total liabilities and stockholders’ deficit
$ 378,287
$ 409,033
THE REALREAL, INC.
Condensed Statements of Cash Flows
(In thousands)
(Unaudited)
Six Months Ended June 30,
2026
2025
Cash flows from operating activities:
Net income
$ 11,703
$ 51,034
Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization
15,917
16,631
Stock-based compensation expense
13,848
15,567
Reduction of operating lease right-of-use assets
8,562
7,943
Bad debt expense
1,342
1,214
Non-cash interest expense
3,227
5,483
Accretion of debt discounts and issuance costs
940
1,060
Provision for inventory write-downs and shrinkage
1,810
1,485
Gain on debt extinguishment
—
(37,101)
Change in fair value of warrant liability
(28,752)
(47,040)
Loss (gain) related to warehouse fire, net
—
(353)
Other adjustments
78
(36)
Changes in operating assets and liabilities:
Accounts receivable, net
2,407
(10,020)
Inventory, net
(6,398)
(6,678)
Prepaid expenses and other current assets
2,913
6,595
Other assets
(479)
(501)
Operating lease liability
(11,100)
(10,876)
Accounts payable
(266)
2,357
Accrued consignor payable
(16,435)
(13,709)
Other accrued and current liabilities
(14,538)
(14,743)
Other noncurrent liabilities
213
(152)
Net cash used in operating activities
(15,008)
(31,840)
Cash flow from investing activities:
Insurance proceeds related to warehouse fire
—
2,309
Capitalized proprietary software development costs
(6,837)
(6,483)
Purchases of property and equipment
(11,502)
(12,518)
Net cash used in investing activities
(18,339)
(16,692)
Cash flow from financing activities:
Proceeds from exercise of stock options
308
114
Taxes paid related to restricted stock vesting
(109)
(83)
Repayment of 2025 Notes
—
(26,749)
Proceeds from issuance of stock in connection with the Employee Stock Purchase
Program
1,018
838
Cash received from settlement of capped calls in conjunction with the 2025 Note
Exchanges
—
1,499
Issuance costs paid related to the 2025 Note Exchanges
—
(5,006)
Net cash provided by (used in) financing activities
1,217
(29,387)
Net decrease in cash, cash equivalents and restricted cash
(32,130)
(77,919)
Cash, cash equivalents and restricted cash
Beginning of period
166,039
187,123
End of period
$ 133,909
$ 109,204
The following table reflects the reconciliation of net income (loss) to Adjusted EBITDA for each of the periods indicated
(in thousands):
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
Adjusted EBITDA Reconciliation:
Net income (loss)
$ (27,233)
$ (11,366)
$ 11,703
$ 51,034
Net income (loss) (% of revenue)
(14.1) %
(6.9) %
3.1 %
15.7 %
Depreciation and amortization
7,823
8,256
15,917
16,631
Interest income
(902)
(1,109)
(1,903)
(2,483)
Interest expense
7,322
7,038
14,543
13,358
Provision for income taxes
101
89
209
184
EBITDA
(12,889)
2,908
40,469
78,724
Stock-based compensation
7,575
8,208
13,848
15,567
Payroll tax expense on employee stock transactions
263
260
1,036
799
Gain on extinguishment of debt (1)
—
—
—
(37,101)
Change in fair value of warrant liability (2)
18,583
(4,537)
(28,752)
(47,040)
Adjusted EBITDA
$ 13,532
$ 6,839
$ 26,601
$ 10,949
Adjusted EBITDA (% of revenue)
7.0 %
4.1 %
7.0 %
3.4 %
(1) The gain on extinguishment of debt for the six months ended June 30, 2025 reflects the difference between the carrying value of the February 2025
Exchanged Notes and the fair value of the 2031 Notes.
(2) The change in fair value of warrant liability for the three and six months ended June 30, 2026 and June 30, 2025 reflects the remeasurement of the Warrants
issued by the Company in connection with the 2024 Note Exchange in February 2024.
A reconciliation of GAAP net income (loss) to non-GAAP net loss attributable to common stockholders, the most directly
comparable GAAP financial measure, in order to calculate non-GAAP net loss attributable to common stockholders per share,
basic and diluted, is as follows (in thousands, except share and per share data):
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
Net income (loss)
$ (27,233)
$ (11,366)
$ 11,703
$ 51,034
Stock-based compensation
7,575
8,208
13,848
15,567
Payroll tax expense on employee stock transactions
263
260
1,036
799
Provision for income taxes
101
89
209
184
Gain on extinguishment of debt
—
—
—
(37,101)
Change in fair value of warrant liability
18,583
(4,537)
(28,752)
(47,040)
Non-GAAP net loss attributable to common stockholders
$ (711)
$ (7,346)
$ (1,956)
$ (16,557)
Weighted-average common shares outstanding to calculate
Non-GAAP net loss attributable to common stockholders
per share, basic and diluted
121,023,931
114,044,057
120,277,907
113,046,607
Non-GAAP net loss attributable to common stockholders
per share, basic and diluted
$ (0.01)
$ (0.06)
$ (0.02)
$ (0.15)
The following table presents a reconciliation of net cash provided for (used in) operating activities to free (negative) cash flow
for each of the periods indicated (in thousands):
Three Months Ended June 30,
Six Months Ended June 30,
2026
2025
2026
2025
Net cash provided by (used in) operating activities
$ 1,615
$ (3,570)
$ (15,008)
$ (31,840)
Purchase of property and equipment and capitalized
proprietary software development costs
(7,699)
(11,423)
(18,339)
(19,001)
Free (negative) cash flow
$ (6,084)
$ (14,993)
$ (33,347)
$ (50,841)
Key Financial and Operating Metrics:
June 30,
2024
September 30,
2024
December 31,
2024
March 31,
2025
June 30,
2025
September 30,
2025
December 31,
2025
March 31,
2026
June 30,
2026
(In thousands, except AOV and percentages)
GMV
$440,914
$433,074
$503,534
$490,405
$504,105
$519,814
$615,683
$606,359
$617,260
NMV
$329,422
$335,191
$383,447
$370,757
$379,377
$397,062
$466,924
$458,747
$470,392
Consignment
Revenue
$112,714
$116,908
$128,126
$123,814
$128,620
$134,429
$149,014
$145,893
$148,216
Direct Revenue
$ 16,724
$ 15,623
$ 19,524
$ 20,454
$ 20,495
$ 22,928
$ 27,214
$ 25,808
$ 25,787
Shipping Services
Revenue
$ 15,496
$ 15,224
$ 16,345
$ 15,765
$ 16,073
$ 16,216
$ 17,823
$ 18,014
$ 18,568
Number of Orders
820
829
870
869
868
890
960
938
937
Take Rate
38.5 %
38.6 %
37.7 %
38.6 %
37.9 %
37.9 %
36.5 %
36.4 %
35.9 %
Active Buyers
942
958
972
985
1,001
1,024
1,056
1,083
1,107
AOV
$ 538
$ 522
$ 579
$ 564
$ 581
$ 584
$ 641
$ 646
$ 659
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-realreal-announces-second-quarter-2026-results-302845414.html
SOURCE The RealReal
You may like
Technology
Chainguard Named a CVE Numbering Authority, Advancing Open Source Vulnerability Disclosure
Published
28 minutes agoon
September 22, 2026By
Authorization enables Chainguard to assign CVEs for qualifying open source vulnerabilities processed through Athena, helping protect open source software from AI attacks
NEW YORK, Sept. 22, 2026 /PRNewswire/ — Chainguard, the trusted source for open source, today announced that it has been authorized by the Common Vulnerabilities and Exposures (CVE®) Program as a CVE Numbering Authority (CNA). The mission of the CVE Program is to identify, define, and catalog publicly disclosed cybersecurity vulnerabilities. As a CNA, Chainguard can assign CVE identifiers and publish CVE Records for qualifying vulnerabilities. The authorization is scoped to include open source vulnerabilities processed through the Athena coalition, when upstream maintainers have already fixed the flaw without an identifier, no maintainer remains to assign one, or no more specific CNA covers the project.
This milestone underscores Chainguard’s deep commitment to transparent, coordinated vulnerability disclosure and protecting open source software from AI attacks. Frontier AI models are surfacing latent vulnerabilities in widely used open source software that traditional security tools and years of expert review failed to detect. As AI compresses the time between discovery and exploitation, vulnerabilities without CVE identifiers may remain invisible to the scanners, databases, and compliance systems organizations rely on to identify and prioritize risk.
“AI-driven zero-day discovery is pushing traditional approaches to vulnerability handling and disclosure to the breaking point,” said Quincy Castro, Chief Information Security Officer, Chainguard. “Through Athena, we are working to get fixes as quickly as possible into as many hands as possible. Becoming a CNA allows us to communicate about vulnerability fixes in a ‘language’ familiar to many organizations and open source maintainers.”
The designation strengthens Athena, Chainguard’s industry coalition for the orchestrated defense of open source software, by providing precise affected and fixed version ranges and technical details that help organizations assess their exposure, reduce false positives, and take appropriate action. Chainguard’s CVE Records also defer to maintainers and project-specific CNAs wherever they exist. With the help of coalition members and mitigation partners, such as Akamai, BNY, Cisco, Cloudflare, JPMorganChase, Kyndryl, Morgan Stanley, and Upwind, Athena validates AI-discovered vulnerabilities, and develops fixes, then partners with Akrites to carry vulnerabilities through disclosure and toward durable upstream remediation.
To learn more about how Chainguard advances open source vulnerability discovery through Athena, visit chainguard.dev/athena.
About Chainguard
Chainguard is the trusted source for open source. By providing engineers and AI agents with hardened, trusted, and production-ready artifacts, Chainguard helps organizations prevent AI supply chain attacks, increase engineering velocity while reducing toil, and maintain continuous compliance. Customers include Fortune 500 enterprises and global industry leaders, including Anduril, Canva, DocuSign, OpenAI, Public Storage, Snap Inc., and Snowflake. Chainguard is venture-backed by leading investors, including Amplify, IVP, Kleiner Perkins, Lightspeed Venture Partners, Mantis VC, Redpoint Ventures, Sequoia Capital, and Spark Capital. For more information, visit: https://www.chainguard.dev/
Brittany Hendrickson, press@chainguard.dev
View original content to download multimedia:https://www.prnewswire.com/news-releases/chainguard-named-a-cve-numbering-authority-advancing-open-source-vulnerability-disclosure-302886770.html
SOURCE Chainguard
Technology
Coveo announces its intention to repurchase for cancellation 2,615,859 subordinate voting shares held by a subsidiary of Qatar Investment Authority
Published
28 minutes agoon
September 22, 2026By
MONTREAL, Sept. 22, 2026 /CNW/ — Coveo (“Coveo” or the “Company”) (TSX: CVO), the leader in AI-Relevance, delivering best-in-class search and generative experiences, today announced that it has entered into an agreement with Al-Rayyan Holding LLC (“Al-Rayyan”), a wholly-owned subsidiary of Qatar Investment Authority (“QIA”), to repurchase for cancellation 2,615,859 Subordinate Voting Shares of Coveo (“SVS”) held by Al-Rayyan (the “Repurchase”) immediately following the conversion by Al-Rayyan of an equivalent number of Multiple Voting Shares of Coveo (“MVS”), for a total repurchase price of approximately C$9,809,471. In addition, Al-Rayyan will pay Coveo a transaction fee.
The Repurchase will be completed at a price of $3.75 per SVS, which represents a discount of 10.5% on the closing price of the SVS on the Toronto Stock Exchange (“TSX”) on September 22, 2026. The purchase price will be paid using cash on hand.
In a separate concurrent transaction (the “Brokered Sale” and, together with the Repurchase, the “Transactions”), Al-Rayyan intends to dispose of an additional 4,800,000 SVS for aggregate consideration of $18,000,000, immediately following the conversion by Al-Rayyan of an equivalent number of MVS, through a separate prospectus-exempt bought deal block trade led by RBC Dominion Securities Inc. (“RBC”). In addition, Al-Rayyan will pay RBC a commission. Completion of the Repurchase is conditional upon completion of the Brokered Sale. Upon completion of the Transactions, Al-Rayyan will cease to hold any equity interest in Coveo.
The board of directors of Coveo (the “Board”) approved the Repurchase after considering, among other factors, the Company’s financial position and capital requirements and the terms of the Repurchase. The Board determined that the Repurchase represents an efficient use of excess capital, in addition to being immediately accretive to the Company’s shareholders. The Transactions also facilitate an orderly exit of Al-Rayyan’s investment in Coveo, and are expected to enhance trading liquidity by increasing the Company’s public float. The Repurchase demonstrates Coveo’s conviction in its business and the Board’s strong belief that Coveo’s SVS remain undervalued.
The Repurchase constitutes a “related party transaction” within the meaning of Regulation 61-101 Protection of Minority Security Holders in Special Transactions (“Regulation 61-101”) as Al-Rayyan is a “related party” of the Company within the meaning of Regulation 61-101. The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements under Regulation 61-101 on the basis that the fair market value of the SVS being repurchased and the consideration to be received by Al-Rayyan in respect of the Repurchase do not exceed 25% of the Company’s market capitalization determined in accordance with sections 5.5(a) and 5.7(1)(a) of Regulation 61-101, respectively. Closing of the Transactions is expected to occur on or before September 24, 2026, which is less than 21 days from the date hereof. Such shorter period is consistent with market practice and the Company believes is reasonable and necessary in the circumstances as it wishes to complete the Transactions in an expeditious manner.
Early Warning Disclosure
Prior to the Transactions, QIA, through Al-Rayyan, had beneficial ownership of, or control and direction over, 7,415,859 MVS, representing approximately 18.5% of the issued and outstanding MVS on an undiluted basis and approximately 16.4% of the aggregate voting rights associated with the issued and outstanding MVS and SVS. Immediately prior to the Transactions, QIA converted such MVS into 7,415,859 SVS, representing approximately 12.2% of the issued and outstanding SVS on an undiluted basis and approximately 1.9% of the aggregate voting rights associated with the issued and outstanding MVS and SVS. QIA has caused Al-Rayyan to undertake the Transactions to monetize QIA’s investment in Coveo.
This press release and QIA’s corresponding early warning report, which is expected to be filed on SEDAR+ in the near term, constitutes the required disclosure pursuant to pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.
QIA’s head office is located at Ooredoo Tower (Building 14), Al Dafna Street (Street 801), Al Dafna (Zone 61), Doha, Qatar. Al-Rayyan exists under the laws of Qatar. Coveo’s head office is located at 1100 Av. Des Canadiens-de-Montréal, Suite 401, Montréal, Quebec, Canada.
Forward-Looking Information
This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws, including statements relating to the Transactions (including with respect to the timing of settlement, completion and anticipated benefits thereof), and other statements that are not historical facts (collectively, “forward-looking information”). This forward-looking information is identified by the use of terms and phrases such as “may”, “would”, “should”, “could”, “might”, “will”, “achieve”, “occur”, “expect”, “intend”, “estimate”, “anticipate”, “plan”, “foresee”, “believe”, “continue”, “target”, “opportunity”, “strategy”, “scheduled”, “outlook”, “forecast”, “projection”, or “prospect”, the negative of these terms and similar terminology, including references to assumptions, although not all forward-looking information contains these terms and phrases. In addition, any statements that refer to expectations, intentions, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates, and projections regarding future events or circumstances.
Forward-looking information is necessarily based on a number of opinions, estimates, and assumptions that we considered appropriate and reasonable as of the date such statements are made. Although the forward-looking information contained herein is based upon what we believe are reasonable assumptions, actual results may vary from the forward-looking information contained herein. Forward-looking information is subject to known and unknown risks, uncertainties, and other factors, many of which are beyond our control, that may cause the actual results, level of activity, performance, or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to macro-economic uncertainties and the risk factors described under “Risk Factors” in the Company’s most recently filed Annual Information Form available under our profile on SEDAR+ at www.sedarplus.ca. There can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date made. Moreover, we operate in a very competitive and rapidly changing environment. Although we have attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward- looking information, there may be other risk factors not presently known to us or that we presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.
You should not rely on this forward-looking information, as actual outcomes and results may differ materially from those contemplated by this forward-looking information as a result of such risks and uncertainties. Except as required by law, we do not assume any obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
About Coveo
Coveo brings superior AI-Relevance to every point-of-experience, transforming how enterprises connect with their customers and employees to maximize business outcomes.
Relevance is about moving from person to person, the degree to which the enterprise-wide content, products, recommendations, and advice presented to a person online aligns easily with their context, needs, preferences, behavior and intent, setting the competitive experience gold standard. Every person’s journey is unique, and only AI can solve the complexity of tailoring experiences across massive, diverse audiences and large volumes and variety of content and products.
Stay up to date on the latest Coveo news and content by subscribing to the Coveo blog, and following Coveo on LinkedIn and YouTube.
SOURCE Coveo Solutions Inc.
Technology
OxiWear and Alfardan Medical with Northwestern Medicine (AMNM) Announce Exclusive Distribution Partnership in Qatar
Published
28 minutes agoon
September 22, 2026By
Partnership marks an important step in OxiWear’s international expansion and growing presence in the Middle East
ARLINGTON, Va. and DOHA, Qatar, Sept. 22, 2026 /PRNewswire/ — OxiWear Inc., a wearable technology company focused on continuous physiological measurements, today announced an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) in Qatar.
The partnership brings together OxiWear’s wearable measurement technology with AMNM’s established presence, local expertise, and network in Qatar, supporting OxiWear’s continued expansion across the Middle East.
The partnership marks another milestone in OxiWear’s international growth as the company continues to expand its technology and build strategic relationships across the United States and international markets.
“Qatar has built an incredible ecosystem around technology and innovation, and we are excited to partner with AMNM as we continue expanding OxiWear internationally,” said Shavini Fernando, Founder and CEO of OxiWear. “Having a strong local partner that understands the market and shares our long-term vision is incredibly important to us. We see significant opportunities for OxiWear in Qatar and across the region, and we look forward to working closely with Dr. Abdulla and the AMNM team to build that presence.”
Under the partnership, the organizations will collaborate on distribution, market development, customer engagement, and opportunities for OxiWear across Qatar.
“We are pleased to partner with OxiWear and support the company’s expansion into Qatar,” said Dr. Abdulla Al-Ansari, CEO of AMNM. “Innovation and the introduction of new technologies are important to the continued development of Qatar’s ecosystem. OxiWear’s approach to continuous physiological measurements presents exciting opportunities across a range of applications, and we look forward to working together to establish and grow its presence in Qatar.”
The partnership is part of OxiWear’s broader international expansion strategy and reflects the company’s focus on establishing strong local relationships as it enters and develops new markets.
About OxiWear: OxiWear Inc. is a wearable technology company developing solutions for continuous physiological measurements. Through its wearable technology and connected platform, OxiWear is building new ways to capture physiological data continuously across a range of environments and applications. Headquartered in Arlington, Virginia, OxiWear works with organizations and partners in the United States and internationally across research, performance, industrial, and other markets.
For more information, visit oxiwear.com.
Alfardan Medical with Northwestern Medicine (AMNM) is a multi-specialty private day-care surgery center located in Lusail, Qatar, operating in affiliation with Northwestern Medicine, the Chicago-based academic health system. AMNM brings together internationally trained physicians, advanced surgical facilities, and Northwestern Medicine’s clinical standards to deliver high-quality, patient-centered outpatient care across a wide range of specialties. Committed to innovation and clinical excellence, AMNM works to introduce new medical technologies and best practices that advance healthcare in Qatar and the wider region.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oxiwear-and-alfardan-medical-with-northwestern-medicine-amnm-announce-exclusive-distribution-partnership-in-qatar-302886771.html
SOURCE OxiWear
Chainguard Named a CVE Numbering Authority, Advancing Open Source Vulnerability Disclosure
Coveo announces its intention to repurchase for cancellation 2,615,859 subordinate voting shares held by a subsidiary of Qatar Investment Authority
OxiWear and Alfardan Medical with Northwestern Medicine (AMNM) Announce Exclusive Distribution Partnership in Qatar
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology2 days agoNew IBM CHRO Study: AI Puts Critical Thinking at the Center of Workforce Priorities
-
Technology4 days agoPeoplevine Secures Multi-Million-Dollar Growth Investment to Accelerate AI-Powered Hospitality
-
Technology2 days agoMCP Is the New NDC — Is This Travel’s Shift-to-Streaming Moment?
-
Technology2 days ago01F Group Announces Investment in DANA, Indonesia’s Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia’s Fintech Opportunity
-
Technology4 days ago
Saturday, September 19, 2026
-
Technology4 days ago4Humanity Introduces the National Positivity Portal, Using AI to Make the Good Happening Across America Easier to See
-
Technology5 days agodtcpay Welcomes SBI Group as Strategic Investor, Extending Series A to US$25M
-
Technology1 day agoFluxnium Secures $7 Million Seed Round to Build a New Domestic Supply of Uranium
